Gradientech AB is a company specializing in the development of advanced diagnostic solutions for microbiology. The firm has created the QuickMIC® system, which offers ultra-rapid antimicrobial susceptibility testing (AST). This system is designed to deliver clinically actionable minimum inhibitory concentration (MIC) results within a timeframe of 2 to 4 hours, significantly enhancing laboratory efficiency and reliability.
The QuickMIC® system is noted for its superior precision in testing and compact design, making it suitable for various laboratory settings. Gradientech's technology aims to assist healthcare providers in combating antibiotic resistance, a growing concern in medical practice. The company has achieved routine clinical use of its system in Austria and has recently submitted its technology for U.S. FDA 510(k) clearance, indicating its commitment to regulatory compliance and innovation in the field of microbiology diagnostics.